Evidence map›Paper›PMID 40177464›Full record

ArticleISME communications2025

Use of MALDI-TOF mass spectrometry and IDBac to mine for understudied bacterial genera from the environment.

Antonio Hernandez, Nyssa K Krull, Brian T Murphy

Abstract read
In one paragraph

Article in ISME communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Antonio HernandezDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, United States.
Nyssa K KrullDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, United States.
Brian T MurphyDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607, United States.

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
MALDI-TOF MS/IDBac to discover antibiotics from the Great Lakes sponge microbiomeR01GM125943 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MURPHY, BRIAN THACHER, SANCHEZ, LAURA MARGARET · 2018 to 2021
$2.1M
NCATS NIH HHS UL1 TR002003NIGMS NIH HHS R01 GM125943
6 · The paper itself

Abstract

Bacterial natural products have greatly contributed to the global drug discovery effort. Further, the incorporation of understudied bacterial taxa into discovery pipelines remains a promising approach to supply much needed chemical diversity to this effort. Unfortunately, researchers lack rapid and efficient techniques to accomplish this. Here we present an approach that employs matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) and the bioinformatics platform IDBac to perform targeted isolation of understudied bacteria from environmental samples. A dendrogram of MS protein spectra from 479 unknown bacterial isolates was seeded with spectra from 50 characterized strains that represented target understudied genera. This method was highly effective at identifying representatives from target taxa, demonstrating an 86.3% success rate when an estimated genus level cutoff was implemented in the dendrogram. Overall, this study shows the potential of MALDI-MS/IDBac to mine environmental bacterial isolate collections for target taxa in high-throughput, particularly in the absence of proprietary software. It also provides a cost-effective alternative to morphology and gene-sequencing analyses that are typically used to guide identification and prioritization strategies from large bacterial isolate collections.

Indexed as

bacteriadatabaseIDBacMALDImass spectrometrynatural products

Identifiers

PMID40177464
PMCPMC11962939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.